Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Sosei Group ( (JP:4565) ) is now available.
Nxera Pharma, a technology-driven biopharma specializing in specialty medicines and GPCR-based drug discovery, has built a growing commercial presence in Japan and APAC while advancing a broad pipeline through internal R&D and partnerships. The company leverages its NxWave platform from bases in Tokyo, Osaka, London, Cambridge, Basel and Seoul and is listed on the Tokyo Stock Exchange under ticker 4565.
Nxera will receive a US$10 million milestone payment from AbbVie after achieving a third research milestone in their multi-target collaboration on neurological diseases, underscoring steady progress in the partnered pipeline. The payment follows the successful identification of validated and differentiated hit molecules against a neurology target, and forms part of a deal that could yield up to US$40 million in near-term research milestones and as much as US$1.2 billion in longer-term option, development and commercial payments plus tiered royalties, reinforcing Nxera’s position in neurology drug discovery and providing meaningful non-dilutive funding for its operations.
The most recent analyst rating on (JP:4565) stock is a Buy with a Yen1400.00 price target. To see the full list of analyst forecasts on Sosei Group stock, see the JP:4565 Stock Forecast page.
More about Sosei Group
Nxera Pharma is a technology-powered biopharmaceutical company focused on developing specialty medicines to address unmet medical needs in Japan and globally. It combines a next-generation commercial business in Japan and the broader APAC region with an extensive pipeline built on its proprietary NxWave GPCR structure-based drug discovery platform, operating from hubs in Japan, the UK, Switzerland and South Korea.
YTD Price Performance: 26.36%
Average Trading Volume: 854,181
Technical Sentiment Signal: Hold
Current Market Cap: Yen94.57B
Find detailed analytics on 4565 stock on TipRanks’ Stock Analysis page.